{
    "nctId": "NCT01899690",
    "briefTitle": "Antibiotics and Tissue Expanders in Breast Reconstruction",
    "officialTitle": "Impact of Prophylactic Perioperative Antibiotic Administration on Surgical Site Infections Following Implant-based Breast Reconstruction.",
    "overallStatus": "WITHDRAWN",
    "conditions": "Complications; Breast Prosthesis, Infection or Inflammation",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Surgical site infection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients in whom implant-based breast reconstruction is selected based on clinician recommendation, patient agreement, and mutual consensus.\n* Ability to understand the purposes and risks of the study and willingly give standard written informed consent for treatment established by Emory University Hospital and affiliates.\n\nExclusion Criteria:\n\n* Pregnancy\n* Incarceration\n* Non-implant based reconstructive plan\n* Any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}